Ko Sasaki
Tochigi, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Pre-transplant molecular international prognostic scoring system score reduction is not associated with improved outcomes in myelodysplastic syndromes.
Journal: Blood cancer journal
Published: March 24, 2026
HDAC inhibitors repress Tek and Angpt1 expression and proliferation in RUNX1-MECOM-type leukemia cells.
Journal: Leukemia research
Published: December 22, 2024
A CML Patient Carrying BCR::ABL1 Splicing Variants Did Not Experience Blast Crisis for 15 Years without Responding to Various TKIs.
Journal: Internal medicine (Tokyo, Japan)
Published: August 28, 2024
Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12).
Journal: International journal of hematology
Published: December 01, 2022
Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma.
Journal: Leukemia research reports
Published: October 27, 2021
Essential thrombocythaemia with aggressive megakaryocytosis after myelofibrotic transformation.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 17, 2021
Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia.
Journal: Nature communications
Published: September 18, 2020
PECAM is an effective and safe anthracycline-containing third-line regimen for patients with relapsed or refractory non-Hodgkin lymphoma.
Journal: Leukemia & lymphoma
Published: September 11, 2020
Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy.
Journal: International journal of hematology
Published: September 07, 2020
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Journal: British journal of haematology
Published: June 07, 2020
Last Updated: 09/26/2026